GlassScriptPhysician profile
Donna L Schoenfelder
NPI 1467568428
$727.60
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $288 · 2021: $221.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $277.07 | 2019-2021 | |
| Ibsa Pharma INC. | $77.00 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $65.83 | 2020-2021 | |
| Therapeuticsmd, INC. | $56.87 | 2019-2021 | |
| Roche Diagnostics Corporation | $42.07 | 2019 | |
| Astellas Pharma US INC | $41.26 | 2019-2021 | |
| Covidien LP | $33.17 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.14 | 2019 | |
| Amag Pharmaceuticals, INC. | $17.93 | 2019 | |
| Sobi, INC | $16.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.87 | 2021 | |
| Tris Pharma INC | $14.15 | 2021 | |
| Olympus America INC. | $13.46 | 2021 | |
| Myovant Sciences INC. | $12.98 | 2021 | |
| Amgen INC. | $12.50 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.30 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Schoenfelder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.